277 related articles for article (PubMed ID: 2566675)
21. Zaprinast, but not dipyridamole, reverses hemodynamic tolerance to nitroglycerin in vivo.
De Garavilla L; Pagani ED; Buchholz RA; Dundore R; Bode DC; Volberg ML; Jackson KN; Pratt P; Silver PJ
Eur J Pharmacol; 1996 Oct; 313(1-2):89-96. PubMed ID: 8905333
[TBL] [Abstract][Full Text] [Related]
22. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
Santos-Silva AJ; Cairrão E; Morgado M; Alvarez E; Verde I
Eur J Pharmacol; 2008 Mar; 582(1-3):102-9. PubMed ID: 18234184
[TBL] [Abstract][Full Text] [Related]
23. Gender differences in protein kinase G-mediated vasorelaxation of rat aorta.
Teede H; van der Zypp A; Majewski H
Clin Sci (Lond); 2001 May; 100(5):473-9. PubMed ID: 11294687
[TBL] [Abstract][Full Text] [Related]
24. Effects of various phosphodiesterase-inhibitors, forskolin, and sodium nitroprusside on porcine detrusor smooth muscle tonic responses to muscarinergic stimulation and cyclic nucleotide levels in vitro.
Truss MC; Uckert S; Stief CG; Kuczyk M; Schulz-Knappe P; Forssmann WG; Jonas U
Neurourol Urodyn; 1996; 15(1):59-70. PubMed ID: 8696357
[TBL] [Abstract][Full Text] [Related]
25. Endothelial modulation of vascular relaxation to nitrovasodilators in aging and hypertension.
Shirasaki Y; Su C; Lee TJ; Kolm P; Cline WH; Nickols GA
J Pharmacol Exp Ther; 1986 Dec; 239(3):861-6. PubMed ID: 3025422
[TBL] [Abstract][Full Text] [Related]
26. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
[TBL] [Abstract][Full Text] [Related]
27. Sodium nitroprusside potentiates the depressor response to the phosphodiesterase inhibitor zaprinast in rats.
Dundore RL; Pratt PF; Hallenbeck WD; Wassey ML; Silver PJ; Buchholz RA
Eur J Pharmacol; 1990 Aug; 185(1):91-7. PubMed ID: 1977600
[TBL] [Abstract][Full Text] [Related]
28. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
[TBL] [Abstract][Full Text] [Related]
29. Atrial natriuretic factor in spontaneously hypertensive rats: concentration changes with the progression of hypertension and elevated formation of cyclic GMP.
Takayanagi R; Imada T; Grammer RT; Misono KS; Naruse M; Inagami T
J Hypertens Suppl; 1986 Oct; 4(3):S303-7. PubMed ID: 2878070
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of tyrosine kinase inhibitors on contraction and relaxation of the aortas of normotensive and hypertensive rats.
Zerrouk A; Auguet M; Dabiré H; Brisac AM; Safar M; Chabrier PE
Eur J Pharmacol; 1999 Jun; 374(1):49-58. PubMed ID: 10422640
[TBL] [Abstract][Full Text] [Related]
31. Endothelial regulation of cyclic GMP and vascular responses in hypertension.
Shirasaki Y; Kolm P; Nickols GA; Lee TJ
J Pharmacol Exp Ther; 1988 Apr; 245(1):53-8. PubMed ID: 2834546
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of nitric oxide-guanylate cyclase-dependent and -independent signaling contributes to impairment of beta-adrenergic vasorelaxations by cyclosporine.
El-Mas MM; Sharabi FM; El-Gowilly SM; El-Din MM
Biochem Pharmacol; 2007 Feb; 73(3):359-67. PubMed ID: 17113040
[TBL] [Abstract][Full Text] [Related]
33. Direct effects of quercetin on impaired reactivity of spontaneously hypertensive rat aortae: comparative study with ascorbic acid.
Ajay M; Achike FI; Mustafa AM; Mustafa MR
Clin Exp Pharmacol Physiol; 2006 Apr; 33(4):345-50. PubMed ID: 16620299
[TBL] [Abstract][Full Text] [Related]
34. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
[TBL] [Abstract][Full Text] [Related]
35. The role of cGMP hydrolysing phosphodiesterases 1 and 5 in cerebral artery dilatation.
Kruuse C; Rybalkin SD; Khurana TS; Jansen-Olesen I; Olesen J; Edvinsson L
Eur J Pharmacol; 2001 May; 420(1):55-65. PubMed ID: 11412839
[TBL] [Abstract][Full Text] [Related]
36. Modulation of relaxant responses evoked by a nitric oxide donor and by nonadrenergic, noncholinergic stimulation by isozyme-selective phosphodiesterase inhibitors in guinea pig trachea.
Ellis JL; Conanan ND
J Pharmacol Exp Ther; 1995 Mar; 272(3):997-1004. PubMed ID: 7891355
[TBL] [Abstract][Full Text] [Related]
37. Dilation of retinal arterioles in response to lactate: role of nitric oxide, guanylyl cyclase, and ATP-sensitive potassium channels.
Hein TW; Xu W; Kuo L
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):693-9. PubMed ID: 16431969
[TBL] [Abstract][Full Text] [Related]
38. Effect of endothelium on basal and on stimulated accumulation and efflux of cyclic GMP in rat isolated aorta.
Schini V; Schoeffter P; Miller RC
Br J Pharmacol; 1989 Jul; 97(3):853-65. PubMed ID: 2547488
[TBL] [Abstract][Full Text] [Related]
39. Relaxant effect of a water soluble carbon monoxide-releasing molecule (CORM-3) on spontaneously hypertensive rat aortas.
Failli P; Vannacci A; Di Cesare Mannelli L; Motterlini R; Masini E
Cardiovasc Drugs Ther; 2012 Aug; 26(4):285-92. PubMed ID: 22766583
[TBL] [Abstract][Full Text] [Related]
40. Reversal of nitroglycerin tolerance in vitro by the cGMP-phosphodiesterase inhibitor zaprinast.
Pagani ED; VanAller GS; O'Connor B; Silver PJ
Eur J Pharmacol; 1993 Oct; 243(2):141-7. PubMed ID: 8276063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
